Association of the Smad3 and NFATc2 gene polymorphisms and their serum levels with susceptibility to rheumatoid arthritis in Polish cohorts

• Published in: Clinical and experimental immunology Vol. 179; no. 3; pp. 444 - 453
• Main Authors: Paradowska‐Gorycka, A., Romanowska‐Próchnicka, K., Haladyj, E., Manczak, M., Maslinski, S., Olesinska, M.
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 01.03.2015; BlackWell Publishing Ltd
• Subjects: Arthritis, Rheumatoid - genetics; Arthritis, Rheumatoid - immunology; Case-Control Studies; Disease Progression; DNA Mutational Analysis; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Joints - pathology; Male; Middle Aged; NFATC Transcription Factors - genetics; NFATc2; Original; Poland; Polymorphism, Single Nucleotide; polymorphisms; rheumatoid arthritis; serum levels; Smad3; Smad3 Protein - genetics; T-Lymphocytes - immunology; Poland; NFATc2; Smad3; serum levels; polymorphisms; rheumatoid arthritis
• ISSN: 0009-9104; 1365-2249
• DOI: 10.1111/cei.12482

Summary One among many factors involved in induction of rheumatoid arthritis (RA) are T cells, the differentiation of which depends upon a unique combination of stimulants and subsequent activation of diverse transcription factors. The aim of this study was to identify polymorphic variants in Smad3 and NFATc2 genes and their possible association with susceptibility to and severity of RA. A total of 272 RA patients, 321 for Smad3 and 304 for nuclear factor of activated T cells (NFAT)c2 healthy individuals, were examined for rs6494629 C/T and rs2289263 T/G Smad3 and rs880324 NFATc2 gene polymorphisms using the polymerase chain reaction–fragment length polymorphism (PCR–RFLP) method and TaqMan single nucleotide polymorphism (SNP) genotyping assay, respectively. Serum Smad3 and NFATc2 levels in RA patients and controls were measured by enzyme‐linked immunosorbent assay (ELISA). The rs6494629 C/T Smad3 gene polymorphism under the recessive (TT versus CC+CT) and over‐dominant (CC+TT versus CT) models were associated with RA (P = 0·014 and P = 0·008, respectively). Smad3 rs2289263 T/G revealed differences in the case–control distribution in co‐dominant, recessive and over‐dominant models (P = 0·037, P = 0·010, P = 0·034). Overall, rs6494629 C/T and rs2289263 T/G Smad3 gene polymorphisms were in a weak linkage disequilibrium (LD) with D′ = 0·116 and r2 = 0·004. After Bonferroni correction, the genotype–phenotype analysis showed no significant correlation of the Smad3 rs6494629 C/T and rs2289263 T/G and NFATc2 rs2289263 TT polymorphisms with disease activity, joint damage and extra‐articular manifestation in RA patients. Serum Smad3 and NFATc2 levels were significantly higher in RA patients than in control groups (both P = 0 0000). The present findings indicated that Smad3 genetic polymorphisms may be associated with the susceptibility to RA in the Polish population.